ARIXTRA(R) Physician Adherence to the Prescribing Information in Isolated Superficial Vein Thrombosis (SVT) Patients.
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 31 Mar 2015
At a glance
- Drugs Fondaparinux sodium (Primary)
- Indications Venous thrombosis
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 26 Mar 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 18 Apr 2014 Planned End Date changed from 1 Oct 2014 to 1 Sep 2014 as reported by ClinicalTrials.gov record.
- 01 Feb 2013 Actual initiation date changed from May 2012 to Nov 2012 as reported by ClinicalTrials.gov.